Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Tanezumab Promising for OA Pain; Plus, Filgotinib Investigated for Psoriatic Arthritis

Michele B. Kaufman, PharmD, BCGP  |  August 15, 2018

New research shows tanezumab may be safe and effective for patients with osteoarthritis pain…

Filed under:Drug Updates Tagged with:filgotinibhipkneeKnee Osteoarthritis (OA)osteoarthritis (OA)PainPsoriatic Arthritistanezumab

Lyme Arthritis Treatment Protocols Critical as Lyme Disease Spreads

Carina Stanton  |  August 15, 2018

As Lyme disease and Lyme arthritis spread to new regions in North America, physicians may ned to become aware of their signs and symptoms. Allen C. Steere, MD, says “Lyme arthritis is more complicated to treat than other manifestations of the disease.” Here are some best practices for treating Lyme arthritis…

Filed under:Conditions Tagged with:best practicesBorrelia burgdorferiLyme arthritisLyme Disease

Osteoporosis Drugs Tied to Lower Fracture Risk & Health Costs

Lisa Rapaport  |  August 13, 2018

(Reuters Health)—Older women with osteoporosis who consistently take a bisphosphonate may have a lower risk of fractures and lower total health costs than their counterparts who stop taking these drugs, a U.S. study suggests. Researchers examined data on 294,369 women who were at least 66 years old, insured by Medicare and prescribed osteoporosis medicines for…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:bisphosphonatesfracture riskFracturesOsteoporosisosteoporosis treatments

U.S. to Boost Drug Price Negotiation in Medicare Advantage Health Plans

Reuters Staff  |  August 8, 2018

(Reuters)—The Trump administration said on Tuesday it would give Medicare Advantage health plans for the elderly new tools to negotiate for lower prescription drug prices. The Centers for Medicare and Medicaid Services (CMS) said Medicare Advantage plans will be allowed to require that patients first try certain lower-cost drugs before moving to a more expensive…

Filed under:Legislation & Advocacy Tagged with:Centers for Medicare & Medicaid Services (CMS)drug price negotiationMedicare Advantage health plansTrump administration

All in the Rheumatology Family

Richard Quinn  |  August 8, 2018

Children can inherit many traits from their parents, including an interest in medicine and rheumatology. Here are a few stories of rheumatologists whose children followed in their footsteps…

Filed under:Professional Topics Tagged with:familyMentoringMentorshiprheumatology

EU Grants Marketing Authorization for Hyrimoz; Plus FDA Rejects New Drug Application for Buprenorphine Sublingual Spray

Michele B. Kaufman, PharmD, BCGP  |  August 8, 2018

In late July, the European Commission granted marketing approval for Hyrimoz, which is biosimilar to adalimumab…

Filed under:AnalgesicsBiologics/DMARDsDrug Updates Tagged with:adalimumabBiologics & BiosimilarsBiosimilarsbuprenorphine sublingual sprayDrug SafetyEuropean UnionFDAHyrimozInternationalPainSafetyU.S. Food and Drug Administration (FDA)

ACR Advocates for Access to Viscosupplementation for OA

Kelly Tyrrell  |  August 6, 2018

In several U.S. states, Blue Cross/Blue Shield and other insurers have dropped or are considering dropping coverage of hyaluronic acid injection—or viscosupplementation—for patients with knee osteoarthritis. The decision appears to be based on guidelines published by the American Academy of Orthopaedic Surgeons in 2013, which at that time specified that research had not found hyaluronic…

Filed under:Professional Topics Tagged with:American Academy of Orthopaedic SurgeonsCommittee on Rheumatologic Care (CORC)dropping coveragehyaluronic acid injectionknee osteoarthritisviscosupplementation

Statins Linked to Idiopathic Inflammatory Myositis

Will Boggs, MD  |  July 31, 2018

NEW YORK (Reuters Health)—Statin use is associated with an increased likelihood of developing idiopathic inflammatory myositis (IIM), researchers from Australia report. “[Although] the incidence of IIM is rare, with the increasing use of statins worldwide and the severity of this condition, this study highlights the need for increased awareness of the condition and the importance…

Filed under:ConditionsMyositis Tagged with:idiopathic inflammatory myositismyositisStatinstatin-associated myopathy

Anxiety, Depression May Help Predict Outcome of Low Back Pain Treatment

Lorraine L. Janeczko  |  July 31, 2018

NEW YORK (New York)—Patients with anxiety and depression may be less satisfied than other patients with their chronic low back pain (CLBP) treatments, new research suggests. “Patients with anxiety/depression symptoms experienced more pain severity and more pain-related functional, social, and emotional disability, and they were less satisfied with care, compared with the other groups,” the…

Filed under:ConditionsPain Syndromes Tagged with:anxiety disordersBack painChronic painDepressionlow back painPain Management

Study Supports Safety of Infliximab in Pregnancy

Reuters Staff  |  July 31, 2018

NEW YORK (Reuters Health)—New registry data should help reassure women with Crohn’s disease (CD) who need to continue infliximab during pregnancy that it won’t harm their baby. “The clinical condition of infants born to women with gestational infliximab exposure was similar to those without exposure,” the study team reports online July 19 in the American…

Filed under:Conditions Tagged with:Crohn's diseaseinfantsinfliximabpregnancy

  • « Previous Page
  • 1
  • …
  • 146
  • 147
  • 148
  • 149
  • 150
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences